Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
BTIG has boosted its price target for FTAI Aviation to $335 from $230, maintaining a Buy rating after the company announced a multi-year partnership with CFM International for component and repair support on CFM56 engines. This agreement reinforces FTAI's business trajectory and alleviates concerns about OEM relations. Shares have surged notably ov…
TD Cowen has maintained its Buy rating on Check Point Software stock, setting a $285 price target that suggests considerable market upside. The firm highlights ongoing demand from firewall updates and rapid uptake of Harmony Email and SASE solutions as drivers for the company's positive near-term momentum. Additional analyst endorsements and recent…
Kepler Cheuvreux upgraded its outlook on ProSiebenSat.1 to 'hold' from 'reduce' as the broadcaster’s stock price stabilized near its fundamental worth amid persistent market challenges and structural headwinds in the German TV advertising market. The upgrade follows a period of underperformance linked to the change in ownership and management under…
Martin Kocher, the president of the Austrian central bank, has urged the European Central Bank (ECB) to exercise caution before implementing policy changes in response to ongoing uncertainties. Speaking to German media, Kocher highlighted the need to avoid premature commitments that could complicate future communications, especially when inflation …
Kepler Cheuvreux analyst Richard Withagen has downgraded Coca-Cola HBC's stock from Hold to Reduce, citing potential near-term value destruction due to its pending $3.4 billion acquisition of Coca-Cola Beverages Africa (CCBA). The acquisition introduces execution risk and may dilute profitability, with the enlarged group’s returns likely to be weig…
Austrian central bank governor Martin Kocher has emphasized a measured approach for the European Central Bank (ECB) when considering policy adjustments in response to heightened geopolitical tensions. Speaking in an interview with a German media outlet, Kocher highlighted the risks of premature moves absent clear inflationary direction, stressing t…
Wells Fargo has adjusted its price target for Mosaic (NYSE:MOS) downward to $27 from $28, maintaining an Equal Weight rating. The revision reflects diminished fourth-quarter expectations tied to weaker conditions in the Brazilian market and SSP production cutbacks. Mosaic’s Q4 and full-year 2025 earnings estimates have also been trimmed. Concurrent…
Wells Fargo has increased its price target for Procter & Gamble (NYSE:PG) to $165, up from $158, while reiterating an Overweight rating following the company's fiscal second-quarter earnings. Despite the results meeting modest expectations, the firm points to solid international operations and the possibility of an improved U.S. market as factors t…
Wells Fargo has increased its price target for Clorox to $115 from $108 after the company announced its acquisition of GOJO Industries, producer of Purell hand sanitizer, for $2.25 billion in cash. The move is viewed as a strategic effort to enhance Clorox's product portfolio and growth prospects. The acquisition is expected to be neutral to earnin…
Shares of SLM Corp rose in after-market trading after Wells Fargo increased its price target to $32.00 from $30.00, maintaining an Overweight rating on the student lending firm. The move follows the release of fourth-quarter earnings that exceeded estimates and an outlook signaling robust growth in earnings per share through 2027. Despite some metr…
Wells Fargo has trimmed its price objective for Abbott Laboratories to $122 from $146 while reiterating an Overweight rating. The revision follows Abbott's fourth-quarter earnings release showing a revenue shortfall attributed primarily to the Nutrition segment alongside other temporary setbacks. Despite these challenges, the company’s earnings per…
Wells Fargo has adjusted its price target on RLI Corp to $59 from $62, maintaining an Equal Weight rating despite the company's slower-than-expected revenue growth. The insurer prioritizes profitability over expansion, holding a robust 24% return on equity and consistent dividends, even as property market challenges temper revenue forecasts for 202…
Recent developments surrounding U.S. interest in Greenland have sparked significant market reactions and highlighted persistent uncertainties in international trade and monetary policies. Following intense speculation and shifts in diplomatic stances, markets experienced notable volatility, revealing sector vulnerabilities and geopolitical concerns…
Citigroup is set to undergo further employee reductions in March, subsequent to approximately 1,000 layoffs implemented in January. These forthcoming cuts, expected to impact senior management including managing directors across various business units, are part of CEO Jane Fraser's broader initiative to reduce costs and improve operational efficien…
UBS has downgraded its rating on Northern Star Resources from Buy to Neutral, lowering the price target in response to recent quarterly production shortfalls and increased cost projections. Despite trading near a 52-week high, concerns about production output and escalating expenses have tempered bullish sentiment, with UBS adjusting its forecasts …
BofA Securities has increased its price target on Sanmina-SCI Corp. to $190 from $180, while retaining a Neutral rating as the company approaches its fiscal Q1 2026 earnings release. Market attention centers on Sanmina's evolving revenue dynamics, driven by a transition from NVIDIA to AMD rack builds, and the integration challenges linked with its …
Research from Aletheia indicates that AMD's server CPU business may outperform existing expectations, with recent feedback from cloud service providers and suppliers pointing to stronger market conditions for fiscal 2026. Key investment firms maintain bullish views on AMD, citing solid demand and near sell-out of server CPUs through 2026, while str…
Bank of America analysts suggest that even with forecasts indicating robust GDP and earnings growth, the S&P 500 may not experience significant gains. This is largely attributed to the index's concentration in AI-related stocks, which are less sensitive to economic cycles, contrasting with cyclical sectors that would benefit more directly from an e…
BCA Research analysts have projected that a forthcoming Supreme Court decision invalidating the Trump administration's use of tariffs under a 1977 law could decrease recession probability while increasing the chances of economic stability or growth in the U.S. They forecast impacts on labor markets, consumer finances, and equity valuations dependin…
Roth/MKM has initiated a Buy rating on Insmed (NASDAQ:INSM), setting a $212 price target that indicates significant potential appreciation from present levels. The firm's analysis points to the strong future prospects of Insmed's Brinsupri and Arikayce therapies, underpinned by favorable trial expectations and market adoption. Despite recent revenu…
Jefferies has launched its equity research coverage on Elia Group SA/NV, a major electricity transmission system operator with predominantly regulated operations in Belgium and Germany. The report emphasizes the company's growing regulated asset base, increasing EBITDA, and steady balance sheet growth in line with ongoing infrastructure investments…
Roth/MKM has begun coverage of vTv Therapeutics with a Buy rating and a target price of $58, citing promising prospects for the company's oral diabetes treatment cadisegliatin. Anticipated Phase 3 data and ongoing clinical developments reinforce a positive outlook despite current unprofitability, with key financial and patent details supporting ope…
KeyBanc Capital Markets has maintained its Overweight rating on Microsoft, establishing a $630 price target indicative of nearly 40% potential upside from current levels. The firm's assessment highlights rising enterprise demand for Azure cloud services as a significant growth driver, supported by strong recent revenue gains and further upside fore…
Barclays has revised Tesla's stock price target upward to $360 while retaining an Equalweight rating, prompted by Tesla’s launch of fully autonomous robotaxi rides without safety monitors in Austin. Despite this technological milestone, the robotaxi fleet remains limited and below initial targets, with significant demand outstripping supply. Invest…
KeyBanc Capital Markets has reaffirmed its Overweight stance on Chipotle Mexican Grill's stock, keeping a $45 price target intact even as it lowers the company's 2025 earnings per share forecast. The firm's outlook reflects cautious optimism driven by recent sales trends and favorable valuation levels despite some pressures on future margins.
